|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue: | |||
| General and administrative expenses: | |||
| Development and support | |||
| General and administrative | |||
| Salaries and benefits | |||
| Depreciation and amortization | |||
| Impairment Loss | |||
| Stock-based compensation | |||
| Total operating expenses | |||
| Operating income/(loss) | |||
| Other income (expense): | |||
| Income from Robotic Arm | |||
| Interest expense - long term debt | |||
| Gain on asset disposal | |||
| Interest expense –debt | |||
| Gain/(loss) on disposal and fair-value changes in investments | |||
| Other income | |||
| Net income (loss): | |||
| Net income (loss) per common share*: | |||
| Basic (in Dollars per share) | |||
| Diluted (in Dollars per share) | |||
| Weighted Average shares used in computing Basic (in Shares) | |||
| Weighted Average shares used in computing Diluted (in Shares) |
Loading...